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Abstract
Health-Related Quality of Life (HRQoL) measures are becoming increasingly used in clinical trials
as primary outcome measures. Investigators are now asking statisticians for advice on how to
analyse studies that have used HRQoL outcomes.
HRQoL outcomes, like the SF-36, are usually measured on an ordinal scale. However, most
investigators assume that there exists an underlying continuous latent variable that measures
HRQoL, and that the actual measured outcomes (the ordered categories), reflect contiguous
intervals along this continuum.
The ordinal scaling of HRQoL measures means they tend to generate data that have discrete,
bounded and skewed distributions. Thus, standard methods of analysis such as the t-test and linear
regression that assume Normality and constant variance may not be appropriate. For this reason,
conventional statistical advice would suggest that non-parametric methods be used to analyse
HRQoL data. The bootstrap is one such computer intensive non-parametric method for analysing
data.
We used the bootstrap for hypothesis testing and the estimation of standard errors and confidence
intervals for parameters, in four datasets (which illustrate the different aspects of study design). We
then compared and contrasted the bootstrap with standard methods of analysing HRQoL
outcomes. The standard methods included t-tests, linear regression, summary measures and
General Linear Models.
Overall, in the datasets we studied, using the SF-36 outcome, bootstrap methods produce results
similar to conventional statistical methods. This is likely because the t-test and linear regression are
robust to the violations of assumptions that HRQoL data are likely to cause (i.e. non-Normality).
While particular to our datasets, these findings are likely to generalise to other HRQoL outcomes,
which have discrete, bounded and skewed distributions. Future research with other HRQoL
outcome measures, interventions and populations, is required to confirm this conclusion.
Published: 09 December 2004
Health and Quality of Life Outcomes 2004, 2:70 doi:10.1186/1477-7525-2-70
Received: 09 August 2004
Accepted: 09 December 2004
This article is available from: http://www.hqlo.com/content/2/1/70
© 2004 Walters and Campbell; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
Page 2 of 19
(page number not for citation purposes)
1. Introduction
Health Related Quality of Life (HRQoL) measures are
now frequently used in clinical trials and health services
research, both as primary and secondary endpoints [1].
Investigators are now asking statisticians for advice on
how to plan and analyse studies that have used HRQoL
measures.
HRQoL measures such as the Short Form (SF)-36, Not-
tingham Health Profile (NHP) and European Organisa-
tion for Research and Treatment of Cancer (EORTC)
QLQ-C30 are described in Fayers and Machin [1] and are
usually measured on an ordered categorical (ordinal)
scale. This means that responses to individual questions
are usually classified into a small number of ordered
response categories, e.g. poor, moderate and good. The
responses are often analysed by assigning equally spaced
numerical scores to the ordinal categories (e.g. 0 = 'poor',
1 = 'moderate' and 2 = 'good') and the scores across simi-
lar questions are then summed to generate a HRQoL
score. These 'summated scores' are usually treated as if
they were from a continuous distribution and were Nor-
mally distributed. We will also assume that there exists an
underlying continuous latent variable, Z, that measures
HRQoL (although not necessarily Normally distributed),
and that the actual measured outcomes, X, are ordered cat-
egories that reflect contiguous intervals along this
continuum.
This ordinal scaling of HRQoL measures means they gen-
erate data with discrete, bounded and non-standard distri-
butions, which may lead to several problems in
determining sample size and analysing the data [2,3].
Since HRQoL outcome measures may not meet the distri-
butional requirements (usually that the data have a Nor-
mal distribution) for parametric methods of sample size
estimation and analysis, conventional statistical advice
would suggest that non-parametric methods be used to
analyse HRQoL data.
The bootstrap [4,5] is a data based simulation method for
estimating sample size [6] and analysing data: including
hypothesis testing (p-values), standard error (SE) and
confidence interval (CI) estimation; which involves
repeatedly drawing random samples from the original
data, with replacement. So, in theory, computer intensive
methods such as the bootstrap that make no distribu-
tional assumptions may be more appropriate for estimat-
ing sample size and analysing HRQoL data than
conventional statistical methods.
Conventional methods of analysis of HRQoL outcomes
are extensively described in Fayers and Machin [1] and
Fairclough [7]. They did not use the bootstrap to analyse
HRQoL outcomes. As a consequence of this omission, the
aim of this paper is to compare bootstrap computer simu-
lation methods with standard methods of analysis of
HRQoL measures (particularly the SF-36). We used the
bootstrap for hypothesis testing, estimation of SEs and CIs
for parameters, in four datasets (which illustrate the dif-
ferent aspects of study design). We then compared the
bootstrap with standard methods of analysing HRQoL
outcomes. These standard methods included: t-tests; mul-
tiple regression/analysis of covariance (ANCOVA) models
fitted via ordinary least squares (OLS); response feature
analysis or summary measures such as the Area Under the
Curve (AUC) [8] and Generalised Linear regression Mod-
els (GLMs) [Pages 21–44, [9]] fitted using Generalised
Estimating Equations (GEE) [10].
The remainder of this paper is structured into the follow-
ing sections. The SF-36 HRQoL outcome is briefly
described in Section 2. Section 2 also describes how the
bootstrap can be used for hypothesis testing and confi-
dence interval estimation. Section 2 ends with a descrip-
tion of the four example datasets. The results of
conventional methods of analysis and bootstrap methods
are compared in Section 3. Other issues, such as with-
drawals and study sizes are discussed in Section 4. The
final section (5) ends with a summary and conclusions.
2. Methods
The bootstrap
The term bootstrap derives from the phrase "to pull oneself
up by one's bootstraps". The phrase is thought to be based
on one of the eighteenth century Adventures of Baron
Munchausen by Rudolph Erich Raspe. The Baron had
fallen to the bottom of a deep lake. Just when it looked
like all was lost, he thought to pick himself up by his own
bootstraps [Page 5, [4]]!
The basic idea of the bootstrap involves repeated random
sampling with replacement from the original data, to pro-
duce random samples of the same size of the original sam-
ple, each of which is known as a bootstrap sample, and each
provides an estimate of the parameter of interest, e.g.
mean. The "with replacement" means that any observa-
tion can be sampled more than once in each bootstrap
sample. It is important because sampling without replace-
ment would simply give a random permutation of the
original data, with many statistics such as the mean being
exactly the same [Page 115, [11]]. Repeating the process a
larger number of times provides the required information
on the variability of the estimator, since the standard error
is estimated from the standard deviation of the statistics
derived from the bootstrap samples.
Bootstrap observed value of the test statistic
The bootstrap is mainly used as a method for assessing
statistical accuracy i.e. SE, biases and CIs. Throughout thisHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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paper we shall use the observed value of the test statistic
or parameter estimate as our best guess at the true value of
the unknown parameter or statistic. For example, if we are
interested in estimating the population mean (from a ran-
dom sample) it may seem that the best estimator of the
mean of the population is the mean of all the bootstrap
estimates. This is turns out not to be the case as the mean
of the all the bootstrap means is biased. The observed
sample mean, from the original data, is always the best
estimate of the population mean. The same result applies
for other statistics such as the median and regression
coefficients.
Confidence Interval estimation
Suppose we wish to calculate a 95% confidence interval
for a mean HRQoL from a sample. We take a random sam-
ple, with replacement from this data, of the same size as
the original sample, and calculate the mean HRQoL of the
data, in this bootstrap random sample. We do this repeat-
edly, a large number of times, say 1000. So we now have
1000 bootstrap samples, and 1000 estimates of the sam-
ple mean, one from each bootstrap sample. If these 1000
bootstrap sample means are ordered in increasing value, a
bootstrap 95% confidence interval for the mean would be
from the 25th to the 975th largest values. This is known as
the percentile method and although it is an obvious choice,
it is not the best method for bootstrapping confidence
intervals, because it can have a bias, which one can esti-
mate and correct for. This leads to methods such as the
preferred bias corrected and accelerated (BCa) method [4,5].
Using the bootstrap method, valid bootstrap confidence
intervals can be constructed for all common estimators
such as the sample mean, median, proportion, difference
in means, and difference in proportions. We estimated
BCa bootstrap confidence intervals using the bootstrap
procedure in STATA v8 [12].
According to Efron and Tibshirani [Page 180, [4]] each
interval  , where   and   are the lower and
upper bounds of the interval respectively, can be
described by its length and shape,
'Shape' measures the symmetry of the interval about the
point estimate  . The standard Normal based intervals
are symmetrical about  , and hence have shape = 1.00.
Shape is a measure of skewness of the CI about the point
estimate. A shape > 1.00, implies the CI is positively
skewed, with a long tail to the right, whereas shape < 1.00
implies the CI is negatively skewed.
Hypothesis testing with the bootstrap
Bootstrap methods can also be used for hypothesis test-
ing. The two quantities that we must choose when carry-
ing out a bootstrap hypothesis test are a test statistic and a
null distribution for the data under the null hypothesis. Given
these, we generate bootstrap values of the test statistic
under the null distribution for the data and estimate the
achieved significance level (ASL) by calculating the propor-
tion of the bootstrap values of the test statistics, which are
greater than or equal to the observed value of the test sta-
tistic from the original data.
Several bootstrap test statistics are available for comparing
the distribution of sample data in two independent
groups. In considering a bootstrap hypothesis for compar-
ing the two means, there is no compelling reason to
assume equal variances and so we do not make this
assumption. We used a bootstrap test statistic for compar-
ing two means that use only the assumption of a common
mean, under the null hypothesis [Page 224, [4]].
Linear regression: Model (residual) and case resampling
Standard errors and CIs for regression coefficients can also
be obtained using bootstrap methods. Two different
approaches are possible, case and model (residual) resam-
pling.
For example with the simple linear model, y = a + bx,
where y is the outcome variable and x is a predictor or
explanatory variable, a is the intercept and b is the slope
or gradient of the line, with n (x, y) pairs of HRQoL obser-
vations. Then case-based resampling involves drawing a
bootstrap sample of size n, with replacement from these n
pairs. Ordinary least squares (OLS) are then used to esti-
mate the regression coefficients for this bootstrap sample
of paired cases. Again we do this repeatedly, say 1000
times, so we now have 1000 bootstrap samples and 1000
estimates of the regression coefficients, one from each
bootstrap sample. The standard error of these estimated
coefficients is simply the standard deviation of these 1000
estimates. As before we can calculate BCa confidence inter-
vals for these estimated regression coefficients.
Case-based resampling may be entirely natural for situa-
tions where it is plausible that the (x, y) pairs have been
drawn by random sampling from a population. However,
case based resampling is less appealing if the x values were
controlled for in some way, perhaps by the design of the
study. In this situation the alternative model or residual
based procedures could be used.
For model based resampling the conventional fitted val-
ues and residuals are first obtained from the observed
data. A bootstrap sample of the residuals is then drawn.
These residuals are then added to the original regression
ˆ , ˆ θθ lo up () ˆ θlo ˆ θup
length shape up lo
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equation (and x values) to generate new bootstrap values
for the outcome variable. Ordinary least squares are then
used to estimate the new bootstrap regression coefficients,
for this bootstrap sample. This process (resampling of the
residuals, adding them to the fitted values and estimating
the regression coefficients) is repeated lots of times to esti-
mate standard errors and confidence intervals for the
regression coefficients from the bootstrap samples.
Thus model based resampling is an example of the "para-
metric bootstrap" when the residuals from a parametric
model are bootstrapped to give estimates of the standard
error of the parameters. There is considerable debate
about which form of resampling is more appropriate.
Both forms of resampling can easily be implemented in
STATA [12] and S-PLUS [13]. We now briefly describe the
SF-36 outcome and the four example datasets.
SF-36 Health Survey
The SF-36 is one of the most commonly used HRQoL
measures in the world today. It contains 36 questions
measuring health across eight different dimensions –
physical functioning (PF), role limitation because of phys-
ical health (RP), social functioning (SF), vitality (VT),
bodily pain (BP), mental health (MH), role limitation
because of emotional problems (RE) and general health
(GH). Responses to each question within a dimension are
combined to generate a score from 0 to 100, where 100
indicates "good health" [14]. Thus, the SF-36 generates a
profile of HRQoL outcomes, on eight dimensions, with
discrete, bounded and skewed distributions (see Figures 1
and 2) which makes statistical analysis and interpretation
difficult [1].
The four datasets
There now follows a brief description of the four datasets
which are used throughout the rest of this paper. These
datasets illustrate the use of HRQoL outcomes across a
variety of study designs. There are three types of study:
observational (both cross-sectional and with baseline and
a single follow-up assessment), two group randomised
controlled trial (RCT) and longitudinal RCT (with several
follow-ups).
CPSW Data: Costs & effectiveness of community postnatal support 
workers (CPSW): RCT [15]
This RCT aimed to establish the relative cost-effectiveness
of postnatal support in the community compared to the
usual care provided by community midwives. Six hundred
and twenty-three postnatal women were allocated at ran-
dom to Intervention  (n = 311) or Control  (n = 312)
groups. The intervention consisted of up to 10 home visits
in the first postnatal month of up to three hours duration
by a community postnatal support worker (CPSW). The
main outcomes were HRQoL as measured by the SF-36 at
six weeks postnatally. This study is unusual since no base-
line HRQoL assessment was made. It was felt that it was
inappropriate to assess HRQoL just prior to or immedi-
ately after childbirth.
Our analysis is based on the 495 responders to the six-
week postnatal questionnaire who completed all 36 items
of the SF-36. This sample consisted of 241 women in the
Control group and 254 women in the Intervention group.
We will use this data to illustrate methods for simple two
group cross-sectional comparisons of HRQoL scores using
conventional (e.g. t-test and Mann-Whitney tests) and
bootstrap hypothesis tests. We will also compare standard
Normal theory (t-test) based CIs with their bootstrap BCa
equivalent.
OA Knee Data [16]
The aim of this longitudinal observational study was to
evaluate two condition specific and two generic health
status questionnaires for measuring HRQoL in patients
with Osteoarthritis (OA) of the Knee, and offer guidance
to clinicians and researchers in choosing between them.
Patients were recruited from two settings, knee surgery
waiting listings and rheumatology clinics. Four self-com-
pletion questionnaires including the SF-36 were sent to
the subjects on two occasions 6 months apart. Two hun-
dred and thirty patients returned the questionnaire at ini-
tial assessment, consisting of 118 patients awaiting total
knee replacement (TKR) Surgery and 112 patients attend-
ing Rheumatology outpatient clinics. At the six-month
follow-up assessment, 211 patients returned the question-
naire (109 and 102 in the Surgery and Rheumatology
groups respectively). The data used here are based on the
211 patients returning both assessments.
Since there was a difference in the baseline HRQoL and
sociodemographic characteristics (age and gender) of the
Clinic and Surgery groups, we use this dataset to illustrate
multiple regression/ANCOVA methods with follow-up
HRQoL as the outcome variable and baseline HRQoL,
age, gender and group as covariates. We compare the con-
ventional ordinary least squares (OLS) estimates of stand-
ard error (SE) and Confidence Interval (CI) for the group
regression coefficient with their bootstrap counterparts.
Leg Ulcer RCT data [17]
The aim of this RCT, with one year of follow-up, was to
establish the relative cost-effectiveness of community leg
ulcer clinics that use four layer compression bandaging
versus usual care provided by district nurses. Two hundred
and thirty-three patients with venous leg ulcers were allo-
cated at random to intervention (120) or control group
(113). The intervention consisted of weekly treatment
with four layer bandaging in leg ulcer clinic (Clinic
group) or usual care at home by the district nursing serviceHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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Distribution SF-36 dimensions from CPSW data by group Figure 1
Distribution SF-36 dimensions from CPSW data by groupHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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Distribution SF-36 dimensions from CPSW data by group Figure 2
Distribution SF-36 dimensions from CPSW data by groupHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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(Home group). The primary outcome was time to com-
plete ulcer healing over the one-year follow-up. Secondary
outcomes included HRQoL as measured by the SF-36 at
baseline, three months and 12 months follow-up.
We use these data to illustrate the use of summary meas-
ures such as the AUC for analysing longitudinal data,
using conventional and bootstrap hypothesis tests. We
will also compare standard Normal theory (t-test) based
CIs with their bootstrap BCa equivalent.
Early Rheumatoid Arthritis RCT data [18]
The Early Rheumatoid Arthritis or NAMEIT trial was a 48-
week, randomised, double blind study to compare Neoral
with methotrexate (Neoral) versus placebo plus meth-
otrexate (Placebo) in patients with early severe rheuma-
toid arthritis (RA). The primary efficacy variable in this
study was the attainment of American College of Rheuma-
tology (ACR) criteria for improvement of rheumatoid
arthritis. Secondary efficacy variables included patient
assessment of health related quality of life (HRQoL).
In order to assess the impact of the treatments on patients'
health related quality of life, the SF-36 was completed by
subjects at seven time-points, Week 0 (baseline), Weeks 8,
16, 24, 32, 40, and Week 48 at the end of the study or at
the time of premature withdrawal from the trial.
Three hundred and six subjects at 48 centres were actually
entered into the study. One hundred and fifty-two sub-
jects receiving methotrexate were randomised to the
Neoral treatment group and 154 subjects receiving meth-
otrexate were randomised to the Placebo group. Of the
306 subjects randomised, 227 completed the study. Sev-
enty-nine randomised subjects discontinued from the
study prior to completion.
We use these data to illustrate more complex statistical
models for analysing longitudinal data e.g. a marginal
GLM fitted with GEEs and compare bootstrap SEs and CIs
for the parameters with their conventionally estimated
counterparts.
3. Results
Dataset 1 CPSW Study: simple cross-sectional comparison 
of 6 week HRQoL for the Control vs. Intervention Groups
Figures 1 and 2 show the histograms of the SF-36 dimen-
sion scores at six weeks post-natally for Intervention and
Control groups. The graphs clearly show the bounded,
skewed and discrete nature of the data for the SF-36 from
this study.
Table 1 shows the two sample t-test (with equal variances)
and Mann-Whitney (MW) comparisons of the eight SF-36
dimension scores. If we assume a cut-off of p ≤ 0.05 for
statistical significance, then the t-test suggests significant
differences on two dimensions of the SF-36: RP and SF.
On two other dimensions PF (p = 0.060) and BP (p =
0.065) the p-values are close to the arbitrary cut-off of
0.05, suggesting some differences although these may not
be statistically reliable. The results of the MW tests suggest
significant differences on four dimensions (PF, RP, BP and
Table 1: CPSW Study Simple cross-sectional comparison of 6 week HRQoL for Control vs. Intervention Groups
SF-36 
Dimension
Group n mean sd Mean Diff t-test equal 
σ's P-value
MW test P-
value
Bootstrap P-
value
Physical Control 241 89.9 14.5 2.6 0.060 0.015 0.057
Function Intervention 254 87.3 15.8
Role Control 241 74.3 38.1 9.1 0.009 0.004 0.010
Physical Intervention 254 65.2 39.5
Bodily Control 241 75.6 23.7 4 0.065 0.040 0.062
Pain Intervention 254 71.6 23.8
General Control 241 77.7 17.7 2.4 0.139 0.147 0.131
Health Intervention 254 75.3 18.5
Vitality Control 241 51.1 20.7 1.3 0.498 0.596 0.494
Intervention 254 49.8 21.7
Social Control 241 81.6 22.7 4.7 0.025 0.015 0.024
Function Intervention 254 76.9 24.2
Role Control 241 77.9 36.4 1.1 0.734 0.503 0.737
Emotional Intervention 254 76.8 35.5
Mental Control 241 72.9 17.2 -0.2 0.902 0.972 0.904
Health Intervention 254 73.1 16.7
The bootstrap p-value is based on 5000 bootstrap replications.Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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SF) of the SF-36. The only major contrast between the
interpretation of the results of the MW and t-tests is on the
BP and PF dimensions, where the former test suggests a
difference and later not.
The last column of Table 1 also shows the results of a
bootstrap hypothesis test for comparing two means. It
compares and contrasts the results of the p-values from a
bootstrap hypothesis tests with the p-values from the
standard two sample t-test with equal variances, and the
MW test. Although they report quantitatively different p-
values, the magnitudes are similar, and if we use a cut-off
of p < 0.05 for statistical significance then the qualitative
interpretation of the tests is the same. So in this example
dataset there appears to be little advantage in using the
bootstrap hypothesis tests compared to conventional
hypothesis tests, such as the t-test, for testing equality of
means.
A major limitation of non-parametric methods, such as
the MW test, is that they do not allow for the estimation
of confidence intervals for parameters or allow for the
adjustment of confounding variables such as baseline cov-
ariates. One way to estimate non-parametric CIs is via the
bootstrap method. Table 2 compares and contrasts the
Normal/t-test (equal variances) based confidence inter-
vals with the bootstrap BCa ones.
The estimates and lengths of the CIs are almost identical.
Table 2 also shows that the shape of the BCa CIs is almost
symmetric about the point estimate of the mean differ-
ence except for the RE dimension, where there is some
evidence of asymmetry. So again in this example dataset
there appears little advantage in using the bootstrap BCa
confidence intervals compared to conventional methods
of confidence interval estimation.
The bootstrap (and Normal) confidence intervals are cal-
culated for a characteristic of the distributions (for exam-
ple mean difference). The groups may have differences in
distributions but similar characteristics e.g. mean [15]. For
example, the MW tests suggests a significant difference (in
distributions) for the PF, RP, BP and SF dimensions, but
the bootstrap and Normal confidence limits for two out of
four of these dimensions (PF and BP) includes zero; sug-
gesting no differences in the mean HRQoL between the
groups.
When a hypothesis is tested using the bootstrap, the resa-
mpling is carried out assuming the null hypothesis H0 is
true. Whereas when confidence intervals for mean differ-
ences between two groups are estimated the resampling is
carried out separately for each group. A useful analogy is
with the comparison of proportions in two independent
groups. Here the standard error for the hypothesis test is
different to the standard error of the difference between
Table 2: Comparisons of parametric and bootstrap estimates of confidence intervals for the eight dimensions of the SF-36 from the 
CPSW Study for Control vs. Intervention Groups
SF-36 CIs Interval
Dimension
Mean Difference  Lower  Upper 
Length Shape
Physical Normal (t-test) -2.6 -5.2 0.1 5.4 1.00
Function Bootstrap BCA -5.2 0.0 5.2 0.98
Role Normal (t-test) -9.1 -16.0 -2.3 13.7 1.00
Physical Bootstrap BCA -15.8 -2.3 13.5 1.02
Bodily Normal (t-test) -4.0 -8.2 0.2 8.4 1.00
Pain Bootstrap BCA -8.1 0.3 8.4 1.03
General Normal (t-test) -2.4 -5.6 0.8 6.4 1.00
Health Bootstrap BCA -5.6 0.8 6.4 0.99
Vitality Normal (t-test) -1.3 -5.0 2.5 7.5 1.00
Bootstrap BCA -5.1 2.4 7.5 0.98
Social Normal (t-test) -4.7 -8.9 -0.6 8.3 1.00
Function Bootstrap BCA -8.7 -0.6 8.1 1.03
Role Normal (t-test) -1.1 -7.5 5.3 12.7 1.00
Emotional Bootstrap BCA -7.1 5.6 12.7 1.11
Mental Normal (t-test) 0.2 -2.8 3.2 6.0 1.00
Health Bootstrap BCA -2.8 3.2 6.0 0.98
Mean difference   = Intervention mean - Control mean
BCa confidence intervals based 5000 bootstrap replications.
ˆ θ ˆ θlo ˆ θup
ˆ θHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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the observed proportions used for estimating a confidence
interval [Page 45, [19]].
Dataset 2 OA Knee: comparison of OLS multiple 
regression, bootstrap case and model based resampling SE 
and CI estimates for the group (surgery vs. clinic) 
parameter
Table 3 shows the baseline socio-demographic and
HRQoL characteristics of the two groups of OA patients
those awaiting total knee replacement surgery (Surgical)
and those having pharmacological treatment (Rheuma-
tology). The group of patients awaiting surgery is signifi-
cantly older and has significantly more men than the
Rheumatology group. The Surgical group has significantly
lower levels of PF prior to total knee replacement surgery
than the Rheumatology group. Conversely the Surgical
group has significantly higher levels of GH, V and MH
compared to the Rheumatology clinic patients. For the
other four dimensions of the SF-36 (RP, BP, SF and RE)
there was no evidence of any difference in HRQoL
between the two groups.
We were interested in seeing whether or not there was a
difference in HRQoL in OA patients after TKR surgery
compared with pharmacologically treated patients. From
previous studies using the SF-36 we know that HRQoL
varies with age and gender [14,20]. Since there was a
difference in the baseline HRQoL and socio-demographic
characteristics (age and gender) of the Rheumatology
clinic and TKR surgery groups, we use this dataset to illus-
trate multiple regression/ANCOVA methods with follow-
up HRQoL as the outcome variable and baseline HRQoL,
age, gender and group (TKR surgery or Rheumatology
clinic) as covariates.
The analysis involved using OLS to fit the multiple regres-
sion model with six month follow-up HRQoL as the out-
come variable and age in years at baseline; gender of the
patient (coded 0 for males and 1 for females); baseline
HRQoL and treatment group variable (coded 0 = Clinic, 1
= Surgery) as explanatory covariates. The group regression
coefficient estimate represents the difference in six-month
follow-up HRQoL between the Rheumatology Clinic and
TKR Surgery groups after adjustment for the patient's age,
gender and baseline HRQoL. A positive value for the
regression coefficient indicates the Surgery group has a
better mean HRQoL at six months follow-up than the
Clinic group after adjustment for the other covariates.
Table 4 compares the OLS and bootstrap standard errors
and confidence interval estimates for the group coefficient
from the OA Knee data. All models include age, baseline
HRQoL and gender as covariates in the regression. For the
bootstrap methods the standard errors are the standard
Table 3: Baseline characteristics of the TKR Surgery and Rheumatology Clinic patients from the OA Knee study.
Rheumatology Surgical 95% CI
N Mean SD N Mean SD Mean Diff Lower Upper P-value
Age 
(years)
102 64.2 (11.3) 109 71.1 (8.5) -6.9 -9.6 -4.2 0.001
SF-36 
Dimensio
ns
Physical 
Function
97 28.2 (22.4) 95 21.2 (18.2) 7.0 1.2 12.8 0.019
Role 
Physical
96 11.5 (22.0) 99 12.9 (26.3) -1.4 -8.3 5.4 0.684
Bodily Pain 100 32.0 (19.5) 104 36.3 (23.4) -4.3 -10.3 1.6 0.154
General 
Health
94 43.9 (22.9) 96 57.3 (23.8) -13.3 -20.0 -6.6 0.001
Vitality 98 36.9 (19.0) 99 42.3 (19.3) -5.4 -10.8 0.0 0.050
Social 
Function
100 53.1 (30.6) 101 53.6 (27.6) -0.5 -8.6 7.6 0.910
Role 
Emotional
95 41.1 (44.2) 99 44.1 (44.6) -3.1 -15.6 9.5 0.632
Mental 
Health
99 62.7 (20.9) 100 68.2 (18.8) -5.5 -11.0 0.1 0.054
Gender
Female 71 (69.6%) 59 (54.1%) (15.5%) (2.4%) (27.8%) 0.021†
Male 31 (30.4%) 50 (45.9%)
Total 102 (100%) 109 (100%)
P-values from two independent samples t-test except (†) χ2test.Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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deviations of the coefficients from the 5000 bootstrap re-
samples. For ease of interpretation and comparison only
the estimates for the group coefficient are shown.
The regression analysis suggests that at six month follow-
up TKR surgical patients have significantly better HRQoL
than Rheumatology treated clinic patients on five dimen-
sions of the SF-36 (PF, BP, GH, V and SF) after adjustment
for age, gender and baseline HRQoL. As can be seen from
Table 4 the standard error estimates are almost identical
for the three methods. Similarly the length of the confi-
dence intervals is virtually the same for all three methods.
Although the bootstrap CIs tend to be asymmetric about
the point-estimate of the regression coefficient.
Qualitatively all of the intervals from the three methods
either include or exclude zero so the interpretation of the
group regression coefficient is the same. Therefore, again
in this example dataset, there appears to be little advan-
tage in using bootstrap case or model based re-sampling
to estimate standard errors and confidence intervals com-
pared to conventional methods of confidence interval
estimation from the OLS multiple regression model.
Dataset 3 Leg ulcer: simple cross-sectional comparison of 
AUC for Home vs. Clinic Groups
We are interested in comparing the HRQoL over the one-
year follow-up between the Home and Clinic treated
groups. The two groups were well matched at baseline for
age, gender and HRQoL, except for the RE dimension of
the SF-36, where there was some reliable statistical evi-
dence of a difference (p = 0.052).
The overall HRQoL of the leg ulcer patients over the 12-
month study period (and three HRQoL assessments) can
be summarised by the AUC. If we set the time units for the
AUC calculation as a fraction of a year, then an AUC value
of 100 implies the leg ulcer patient has been in "good
health" for the entire 12-month follow-up period. Con-
versely an AUC value of 0 implies the leg ulcer patient has
been in "poor health" for the entire 12-month follow-up
period.
Table 7 [See additional file 1] gives the results of simple
comparisons of differences in mean AUC between the
groups using the two independent samples t-test, the MW
test and the bootstrap hypothesis test.
Table 4: Comparison of multiple regression, bootstrap case and model based resampling SE and CI estimates from the OA Knee data
Dependent GROUP coefficient 95% CI Interval
Variable Model N SE
/SE
p Lower Upper Length Shape
Physical Function OLS 165 13.3 3.07 4.31 0.001 7.19 19.32 12.14 1.00
Case 3.02 4.39 7.64 19.69 12.05 1.15
Model 3.05 4.35 7.49 19.49 12.00 1.08
Role Physical OLS 177 -0.5 4.89 -0.11 0.915 -10.16 9.12 19.29 1.00
Case 4.39 -0.12 -8.60 8.51 17.11 1.12
Model 4.86 -0.11 -10.11 8.93 19.04 0.99
Bodily Pain OLS 200 14.7 3.39 4.34 0.000 8.01 21.38 13.37 1.00
Case 3.41 4.30 7.81 21.41 13.60 0.98
Model 3.36 4.38 8.07 21.25 13.18 0.99
General Health OLS 173 4.7 2.01 2.32 0.021 0.71 8.65 7.95 1.00
Case 2.03 7.26 0.69 8.69 8.00 1.01
Model 1.98 2.37 0.70 8.48 7.78 0.95
Energy OLS 185 6.5 2.46 2.64 0.009 1.65 11.36 9.72 1.00
Case 2.50 2.60 1.75 11.63 9.88 1.08
Model 2.46 2.65 1.49 11.04 9.54 0.90
Social Function OLS 194 9.1 3.70 2.46 0.015 1.82 16.41 14.59 1.00
Case 3.52 2.59 2.14 16.06 13.92 1.00
Model 3.65 2.50 1.72 16.09 14.37 0.94
Role Emotional OLS 184 9.4 6.10 1.55 0.124 -2.60 21.48 24.08 1.00
Case 5.89 1.60 -1.90 20.85 22.75 1.01
Model 6.03 1.57 -2.37 20.90 23.27 0.97
Mental Health OLS 191 1.1 2.15 0.51 0.613 -3.15 5.33 8.48 1.00
Case 2.32 0.47 -3.54 5.42 8.96 0.94
Model 2.14 0.51 -3.17 5.12 8.28 0.95
Bootstrap BCa confidence intervals based 5000 bootstrap replications.
ˆ β
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The p-values from the t-test and the ASL from the boot-
strap hypothesis tests are very similar. None of the p-val-
ues for the eight SF-36 dimensions are less than 0.05.
Therefore there is no reliable statistical evidence to suggest
a difference in mean AUC between the Clinic and Home
treated leg-ulcer patients. Only the results of the MW test
on the RE dimension of the SF-36 provide (p = 0.071) any
evidence of a difference in AUC distributions between the
groups, although even this p-value is not statistically sig-
nificant using the conventional cut-off of 0.05.
The table also contrasts the Normal theory based CI esti-
mates from the t-test with the bootstrap BCa limits. The
lengths of the intervals are very similar, although the
bootstrap BCa intervals tend to have a non-symmetric
shape. All the estimated CIs include zero, again suggesting
no evidence of a difference in mean AUC (HRQoL)
between the Clinic and Home group patients in the Leg
Ulcer study.
Dataset 4 Early RA: Comparison of robust and bootstrap 
SE's and CI's for the time and group coefficients with a 
GEE marginal model and exchangeable autocorrelation
In the Early RA study, HRQoL assessment was carried out
at 0, 8, 16, 24, 32, 40 and 48 weeks. With seven repeated
HRQoL measurements, such as this, the best approach is
to model the longitudinal data using GLMs.
The modelling of longitudinal data takes into account the
fact that successive HRQoL assessments by a particular
subject are likely to be correlated. We used a marginal
model with the Early RA data and used GEEs to estimate
Table 5: Auto-correlation matrices for the eight dimensions of the SF-36 from RA patients in the Early RA study assessed at seven 
time points
a) Physical Function (n = 218) e) Vitality (n = 216)
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48
0 1.00 0 1.00
8 0.61 1.00 8 0.55 1.00
16 0.63 0.74 1.00 16 0.48 0.58 1.00
24 0.57 0.69 0.75 1.00 24 0.47 0.54 0.71 1.00
32 0.56 0.68 0.80 0.79 1.00 32 0.50 0.59 0.68 0.71 1.00
40 0.55 0.67 0.77 0.81 0.86 1.00 40 0.42 0.49 0.67 0.68 0.77 1.00
48 0.53 0.64 0.74 0.81 0.81 0.85 1.00 48 0.47 0.53 0.66 0.72 0.72 0.76 1.00
b) Role Physical (n = 212) f) Social Function (n = 219)
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48
0 1.00 0 1.00
8 0.40 1.00 8 0.44 1.00
16 0.35 0.53 1.00 16 0.43 0.53 1.00
24 0.29 0.39 0.57 1.00 24 0.39 0.55 0.63 1.00
32 0.19 0.30 0.56 0.67 1.00 32 0.36 0.46 0.63 0.70 1.00
40 0.34 0.42 0.52 0.60 0.61 1.00 40 0.38 0.51 0.58 0.64 0.71 1.00
48 0.27 0.40 0.59 0.67 0.64 0.71 1.00 48 0.34 0.45 0.58 0.64 0.71 0.71 1.00
c) Bodily Pain (n = 219) g) Role Emotional (n = 206)
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48
0 1.00 0 1.00
8 0.43 1.00 8 0.46 1.00
16 0.45 0.55 1.00 16 0.35 0.47 1.00
24 0.44 0.47 0.61 1.00 24 0.34 0.40 0.59 1.00
32 0.37 0.46 0.51 0.68 1.00 32 0.31 0.32 0.56 0.62 1.00
40 0.40 0.42 0.57 0.60 0.69 1.00 40 0.34 0.46 0.53 0.56 0.54 1.00
48 0.42 0.46 0.59 0.63 0.68 0.76 1.00 48 0.31 0.37 0.49 0.58 0.54 0.69 1.00
d) General Health (n = 209) h) Mental Health (n = 218)
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48
0 1.00 0 1.00
8 0.55 1.00 8 0.57 1.00
16 0.56 0.68 1.00 16 0.57 0.62 1.00
24 0.60 0.67 0.80 1.00 24 0.55 0.59 0.72 1.00
32 0.58 0.67 0.77 0.83 1.00 32 0.52 0.55 0.65 0.69 1.00
40 0.59 0.65 0.72 0.79 0.84 1.00 40 0.50 0.54 0.70 0.70 0.74 1.00
48 0.58 0.65 0.75 0.84 0.82 0.85 1.00 48 0.56 0.55 0.68 0.72 0.73 0.77 1.00
Correlations are Pearson's product moment coefficient.Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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the regression coefficients. Marginal models are appropri-
ate when inferences about the population average are the
focus. For example, in a clinical trial the average difference
between control and treatment is most important, not the
difference for any one individual. In a marginal model,
the regression of the response on explanatory variables is
modelled separately from the within-person correlation.
The marginal model is an extension of the linear regres-
sion model used with the OA Knee data. Longitudinal
models require the specification of the auto- or serial corre-
lation, which is the strength of the association between
successive longitudinal measurements of a single HRQoL
variable on the same patient.
Several underlying patterns of the auto-correlation matrix
are used in the modelling of HRQoL data. The error struc-
ture is independent (sometimes termed random) if the off
diagonal terms of the auto-correlation matrix are zero.
The repeated HRQoL observations on the same subject are
then independent of each other, and can be regarded as
though they were observations from different individuals.
On the other hand, if all the correlations are approxi-
mately equal or uniform then the matrix of correlation
coefficients is termed exchangeable, or compound symmetric.
This means that we can re-order (exchange) the successive
observations in any way we choose in our data file with-
out affecting the pattern in the correlation matrix. As the
time or lag between successive observations increases, the
auto-correlation between the observations decreases. A
correlation matrix of this form is said to have an autore-
gressive structure (sometimes called multiplicative or time
series).
Table 5 summarises the resulting 21 auto-correlation pairs
for the assessments until week 48. The pattern of the
observed auto-correlation matrix, gives a guide to the so-
called error structure associated with the successive
HRQoL measurements. Table 5 shows that the autocorre-
lation coefficients range between 0.19 and 0.85. For three
dimensions of the SF-36, PF, GH and MH, the autocorre-
lation coefficients are moderately large (between 0.5 and
0.85). The pattern of values suggests that the assumption
of compound symmetry is not unreasonable.
The process of fitting marginal models using GEE begins
by assuming the simple independence form for the auto-
correlation matrix, and fitting the model as if each assess-
ment were from a different patient. Once this model is
obtained the corresponding residuals are calculated and
these are then used to estimate the autocorrelation matrix
assuming it is of the exchangeable (or autoregressive)
type. This matrix is then used to fit the model again, the
residuals are once more calculated, and the autocorrela-
tion matrix obtained. The iteration process is repeated
until the corresponding regression coefficients that are
obtained in the successive models converge or differ little
on successive occasions [1].
Fayers and Machin [Pages 183–202, [1]] and Diggle et al
[10] emphasise the importance of graphical presentation
of longitudinal data prior to modelling. Figure 3 shows
the mean levels of HRQoL in patients with RA, before and
during treatment, for the eight dimensions of the SF-36.
The curves for some dimensions of the SF-36 overlap (e.g.
PF, GH, RE, and MH dimensions) suggesting that it may
be unrealistic to assume that the mean difference in
HRQoL values on these dimensions remains constant
over time. For other dimensions such as BP, V and SF there
is some evidence to suggest that for later HRQoL measure-
ments the curves are parallel and that the mean difference
between treatments is now fairly constant.
The overlapping lines on some of the graphs in Figure 3
imply there may be a 'Treatment × Time' interaction. It is
therefore important to test for any such interaction in any
regression model. Fortunately, with the marginal model
approach this is relatively easy to do and simply involves
the addition of an extra regression coefficient to the
model. If treatment is coded as a 0/1 variable (i.e. 0 = Pla-
cebo and 1 = Neoral) and assessment time as a continuous
variable, then the additional interaction term is simply
the product of these two variables (which will be 0 for all
the Placebo group patients and equal to the HRQoL
assessment time in the Neoral Group patients).
Early RA marginal model analysis
The marginal model we used for the Early RA data for ana-
lysing the seven HRQoL assessments over time was,
Yij  =  β1  +  βBasexBase_i  +  βAgexAge_i  +  βSexxSex_i  +  βTimetij  +
βGroupxGroup_i + εij,   (2)
where Yij is the HRQoL at time tij post-baseline; tij is the
time of the QoL assessment, in weeks post baseline, of
patient i at visit j; xBase_i is the baseline HRQoL assessment
for subject i; xAge_i is the age (in years) of subject i at time
0 (baseline); xSex_i is the gender of subject i; xGroup_i is the
treatment group (0 = Placebo, 1 = Neoral) for subject i; β1
is a constant and εij is the residual error.
The marginal regression models were fitted in STATA [12]
using the xtgee command with an identity link function
(link (iden)) and the robust standard errors option. The
observed correlation matrices in Table 5 clearly show the
off-diagonal terms are non-zero and that the assumption
of an independent auto-correlation matrix for the mar-
ginal model is unrealistic. We will not consider models
with an independent auto-correlation structure and willHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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Profile of mean SF-36 scores over time by treatment group EARLY RA data (Patients who completed all seven HRQoL  assessments) Figure 3
Profile of mean SF-36 scores over time by treatment group EARLY RA data (Patients who completed all seven HRQoL 
assessments)Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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concentrate on reporting the results of models with an
exchangeable correlation.
None of the interaction term coefficients for the eight SF-
36 dimensions were statistically significant (from zero).
Thus there was no reliable evidence of a 'Treatment ×
Time' interaction on any dimension of the SF-36 (p >
0.05), irrespective of the autocorrelation structure. There-
fore we will only report the results of the simpler model
(2), without the interaction term.
The beauty of the marginal model and the GEE method-
ology is that it is very flexible and can in principle deal
with all the observed data from a HRQoL study. The sub-
jects are not required to have exactly the same numbers of
assessments, and even the assessments can be made at var-
iable times. The latter allows the modelling to proceed
even if a subject misses a HRQoL assessment. So it seems
unrealistic and unreasonable to use bootstrap resampling
methods for marginal models that can only utilise a bal-
anced data set, with equally spaced QoL assessments.
Since we are interested in fitting a marginal model and we
are likely to have an unbalanced dataset with unequal
observations per subject we used simple bootstrap case-
resampling.
Figure 4 shows the estimated within subject correlation
matrices for the eight dimensions of the SF-36 if we fit the
longitudinal model and assume a compound symmetric
structure. The lower diagonal gives the observed matrix
before the model fitting. The fitted autocorrelations
ranged from 0.43 for the RE dimension to 0.63 for the PF
and GH dimensions. On the whole, the model correlation
estimates tend to be lower than the actual observed
autocorrelations, for HRQoL assessments that are close
together. Conversely the model correlation estimates tend
to be larger than the observed correlations for HRQoL
observations further apart in time. It will usually be the
case that after model fitting the autocorrelations will
appear to have been reduced [1]. The observed deviations
between the fitted model and observed autocorrelations
are not too great, suggesting that the assumption of com-
pound symmetry is not unreasonable (Figure 4).
Table 6 shows the estimated regression coefficients for the
group and time variables. There is some evidence that
HRQoL increases over time for three dimensions of the
SF-36, PF, BP and V. However, we are interested in the
effect of treatment and comparing HRQoL over time
across the Placebo and Neoral treated groups. Since there
is no reliable evidence of a 'Group × Time' interaction the
interpretation of the treatment group coefficient is rela-
tively straightforward. The p-values for the treatment
group regression coefficients in Table 6 suggest significant
differences in HRQoL between the Neoral and Placebo
groups on three dimensions of the SF-36 (RP, GH and
BP).
The bootstrap and robust standard errors for the time and
group coefficients are different, although the bootstrap SE
estimate tends to be the same size or somewhat smaller
than its robust counterpart. However both bootstrap and
robust SE estimates are of a similar order of magnitude.
More importantly, the ratios of the estimated coefficient
to its standard error are of similar size.
A crude test of statistical significance is to examine this
ratio, if it is bigger than 2.0 then the estimated regression
coefficient is likely to be significantly different from zero.
Table 6 shows that for all the models where the original
(group or time) regression estimates are significant (i.e.
ratios of estimate/SE > 2) then so too is the ratio of the
estimate to its bootstrap standard error.
When we compare the bootstrap BCa confidence intervals
with the model- based estimates in Table 6 then the length
of the bootstrap intervals tend to be the same size or
slightly narrower than its robust counterpart. As before
the bootstrap estimates are not constrained to be symmet-
ric about the point-estimate of the regression coefficient.
Qualitatively both the bootstrap and model based inter-
vals include zero when the estimated regression
coefficient is non-significant and exclude zero when the
estimated coefficient is significant. Therefore, the actual
practical interpretation of the confidence interval esti-
mates is the same. That is for the RP, BP, and GH dimen-
sions there is some evidence that the Neoral group has a
better HRQoL than the Placebo group patients over time,
after allowing for baseline HRQoL, age and gender.
The use of the bootstrap to estimate SEs and CIs for mar-
ginal longitudinal models appears to offer little advantage
(in the Early RA data) compared to the conventional
robust estimates.
4. Discussion
In the datasets and outcomes studied, and for the specific
conventional analyses we used, we have shown that use of
the bootstrap does not lead to different p-values, SE and
CI estimates compared to conventional methods. On this
basis, we cannot conclude the use of the bootstrap is more
appropriate than conventional methods. The explanation
for this conclusion and the extent of its generalisability
deserve discussion.
Ordinality of HRQoL outcomes
One of the fundamental assumptions we have made, is
that there exists an underlying continuous latent variable
that measures HRQoL, and that the actual measured out-
comes are ordered categories that reflect contiguous inter-Health and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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Observed and estimated within-patient auto-correlation matrices (exchangeable model) from RA patients in the EARLY RA  study Figure 4
Observed and estimated within-patient auto-correlation matrices (exchangeable model) from RA patients in the EARLY RA 
study. The lower diagonal gives the observed matrix before model fitting whilst the upper gives the exchangeable form after 
model-fittingaHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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vals along this continuum. If the goal of the analysis is to
assess the magnitude of the treatment effect on this
ordered outcome, then an appealing approach is to assign
numeric scores to the ordered categories and then to
compare means between groups using conventional lin-
ear regression methods. If interest lies elsewhere, for
example in comparing the relative frequencies of cumula-
tive probabilities in the ordered categories between treat-
ments, then other techniques such as the proportional
odds model would be more appropriate [9,2,21]. Heeren
and D'Agostino [26] have demonstrated the robustness of
the two independent samples t-test when applied to three-
, four- and five point ordinal scaled data using assigned
scores, in sample sizes as small as 20 subjects per group.
Sullivan and D'Agostino [27] have expanded this work to
account for a covariate when the outcome is ordinal in
nature. They again assign numeric scores to the distinct
response categories and compare means between treat-
ment groups adjusting for a covariate reflecting a baseline
assessment measured on the same scale. Their simulation
study shows that in the presence of three-, four- and five
point ordinal data and small sample sizes (as low as 20
per group) that both ANCOVA and the two independent
sample t-test on difference scores are robust and produce
actual significance levels close to the nominal significance
levels.
Table 6: Comparison of robust and bootstrap SE's and CI's from the EARLY RA data with a Marginal Model and exchangeable 
autocorrelation
Dependent Coefficients 95% CI Interval
Variable SE
/SE
p Lower Upper Length Shape
Physical Function (n = 222) time 0.11 0.03 3.63 0.001 0.05 0.18 0.12 1.00
0.03 3.72 0.05 0.18 0.12 0.97
group 2.82 2.25 1.25 0.211 -1.60 7.24 8.84 1.00
1.72 1.64 -0.51 6.13 6.64 0.99
Role Physical (n = 221) time -0.06 0.07 -0.90 0.366 -0.19 0.07 0.26 1.00
0.07 -0.94 -0.19 0.06 0.25 0.91
group 9.49 3.93 2.42 0.016 1.79 17.19 15.40 1.00
3.22 2.95 3.63 16.62 12.99 1.22
Bodily Pain (n = 222) time 0.16 0.03 4.69 0.001 0.10 0.23 0.14 1.00
0.03 4.88 0.10 0.23 0.13 1.05
group 4.23 1.97 2.14 0.032 0.36 8.10 7.74 1.00
1.50 2.82 1.44 7.25 5.81 1.08
General Health (n = 221) time 0.04 0.03 1.67 0.095 -0.01 0.09 0.10 1.00
0.03 1.68 -0.01 0.09 0.10 0.95
group -4.61 1.96 -2.35 0.019 -8.46 -0.76 7.69 1.00
1.51 -3.04 -7.36 -1.28 6.07 1.21
Vitality (n = 220) time 0.09 0.03 3.09 0.002 0.03 0.14 0.11 1.00
0.03 3.05 0.04 0.15 0.11 1.24
group 2.67 1.80 1.48 0.14 -0.87 6.20 7.07 1.00
1.41 1.89 -0.19 5.42 5.61 0.96
Social Function (n = 222) time 0.03 0.03 0.77 0.442 -0.04 0.09 0.13 1.00
0.03 0.79 -0.04 0.09 0.13 0.97
group 2.40 2.11 1.14 0.255 -1.73 6.54 8.27 1.00
1.65 1.46 -0.72 5.88 6.61 1.11
Role Emotional (n = 221) time -0.02 0.07 -0.32 0.752 -0.17 0.12 0.29 1.00
0.08 -0.31 -0.18 0.12 0.30 0.93
group 4.14 3.91 1.06 0.29 -3.52 11.81 15.33 1.00
2.93 1.41 -1.54 10.11 11.64 1.05
Mental Health (n = 221) time 0.02 0.03 0.69 0.489 -0.03 0.07 0.10 1.00
0.03 0.68 -0.03 0.07 0.10 1.15
group 1.53 1.67 0.92 0.359 -1.74 4.79 6.53 1.00
1.34 1.14 -0.93 4.42 5.35 1.18
Note: The bootstrap estimates of SE and BCa Confidence Intervals are shown in italics below the model based estimates and are based on 1000 resamples.
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Generalisability
The generalisability of the results could be called into
question as they only apply to the limited number of data-
sets studied (four) and the SF-36 outcome. The SF-36 out-
come is the most widely used generic HRQoL measure in
the world today, so that is one obvious reason to use it
[22]. Secondly, we had easy access to a variety of datasets
that had previously used the SF-36 outcome. The four
studies (CPSW, OA Knee, Leg Ulcer and Early RA), and
datasets were well known to us. They illustrate the use of
HRQoL outcomes across a variety of studies including
cross-sectional surveys, RCTs, non-randomised before
and after studies and longitudinal designs. So on practical
and pragmatic grounds, we felt it was appropriate to use
such datasets because of their familiar nature and the
analysis was easy to understand and interpret.
The SF-36 is a multi-dimensional outcome with eight
dimensions. As described in the Introduction the eight
dimensions have a variety of distributions. We believe
these distributions are not atypical of other generic
HRQoL measures such as the NHP and EORTC QLQ-C30.
The distributions we considered were chosen based on
our experiences with HRQoL data in a variety of settings.
So we believe that our results about the bootstrap may
have generalisability to other HRQoL outcomes (besides
the SF-36) used in other studies and populations,
although strictly speaking our results only apply to the SF-
36 outcome and the observed datasets. Hence, we cannot
make sweeping generalisations about the impact of the
bootstrap on other HRQoL outcomes, used in other stud-
ies. Therefore, these results need to be replicated with
other HRQoL measures in other datasets and populations.
Missing values
It should be noted that in the all four example datasets
there is missing data. We assumed that any missing
HRQoL values in these datasets were Missing Completely
at Random (MCAR). This means that the probability of
the HRQoL response being missing is independent of the
scores on the previous observed questionnaires and inde-
pendent of the current and future scores had they been
observed. We have assumed that the reduced dataset rep-
resents a randomly drawn sub-sample of the full dataset
and the inferences drawn can be considered reasonable.
This is a strong assumption and unlikely to hold for miss-
ing HRQoL data [1,7,23-25].
Sample sizes of the example datasets
The various datasets used in this study all had a sample
size in excess of 100 patients. Some caution should be
used in applying the results to smaller sample sizes. How-
ever the robustness of the conventional two-sample t-test
and ANCOVA, for three-, four- and five point ordinal scale
data using assigned scores has been demonstrated for
sample sizes as small as 20 [26,27]. Simple bootstrapping
may not be very successful in small samples anyway (say
< 9 observations), since the observations themselves are
less likely to be representative of the study population. As
Campbell [Page 118, [11]] states, "In very small samples
even a badly fitting parametric analysis may outperform a non-
parametric analysis, by providing less variable results at the
expense of a tolerable amount of bias."
The bootstrap
Bootstrap case resampling vs. model based resampling
The results with the OA Knee data show that there is little
to choose from between the case and model based resam-
pling for the multiple linear regression model for estimat-
ing SEs and CIs. Since there was very little difference in the
SE and CI estimates from the datasets used, for simplicity
one would tend to favour a case based resampling
approach. Indeed this was the resampling method for the
longitudinal marginal model for the Early RA data.
Bootstrap model based resampling for marginal model
In the longitudinal Early RA for simplicity we used only a
simple case based resampling for the marginal model and
effectively carried out a stratified random resampling with
replacement. That is we sampled with replacement blocks
or clusters of each patients' repeated HRQoL responses. In
theory, one should be able to use model or residual based
resampling for the marginal model. The resampling pro-
cedure would be rather complex particularly for autore-
gressive autocorrelation structures and for unbalanced
datasets, with HRQoL assessments at unequally spaced
time points. One would have to take into account that the
residuals were not independent and uncorrelated, and for
the autoregressive correlation structure, that the correla-
tion between residuals within a patient declined over
time. This is a very interesting avenue and requires further
exploration with other longitudinal datasets.
Are the results surprising or unexpected?
Finally, are the results all that surprising or unexpected?
We have shown that the use of bootstrap methods for
analysis (calculation of p-values, SE and CIs) appears to
offer little advantage compared to standard methods in
the four datasets studied.
If we assume that there exists an underlying continuous
latent variable that quantifies the HRQoL response of
interest and that the goal of the analysis is to assess the
magnitude of a treatment effect on the HRQoL outcome,
by comparing means between groups. Then statistical the-
ory says that if the distribution of the HRQoL data is Nor-
mal, so will be the distribution of the sample mean. Much
more importantly, even if the distribution of HRQoL data
is not Normal, as is frequently the case, that of the sample
mean will become closer to a Normal distribution as theHealth and Quality of Life Outcomes 2004, 2:70 http://www.hqlo.com/content/2/1/70
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sample size gets larger. This is a consequence of the Cen-
tral Limit Theorem (CLT) [Pages 304-7, [28]]. The Normal
distribution is strictly only the limiting form of the sam-
pling distribution as the sample size increases to infinity,
but it provides a remarkable good approximation to the
sampling distribution even when the sample size is small
and the distribution of the data is far from Normal [Page
94, [29]]. This implies, for example, that the distribution
of the sample means for the SF-36 HRQoL data shown in
Figures 1 and 2 will be approximately Normal.
Thus, if the investigator is planning a large study and the
sample mean is an appropriate summary measure of the
HRQoL outcome, then pragmatically there is no need to
worry about the distribution of the HRQoL outcome and
we can use standard methods to estimate sample sizes and
analyse the data. Since dramatic effects are unlikely in
HRQoL studies using the SF-36 as an outcome, large sam-
ples sizes are likely to be required [2,3,6]. So perhaps
unsurprisingly, the results reflect the robustness of con-
ventional methods with large sample sizes and the appli-
cation of the CLT to sample means even for HRQoL data
with such bounded, discrete and skewed distributions as
shown in Figures 1 and 2.
So our research using the SF-36 HRQoL outcome and the
four datasets has shown that bootstrap methods appear to
produce p-values, SEs and CIs similar to conventional
methods. When the standard and the bootstrap methods
agree, we can be more confident about the inference we
are making and this is an important use of the bootstrap
[Page 118, [11]]. When they disagree more caution is
needed, but the relatively simple assumptions required by
the bootstrap method for validity mean that in general it
is to be preferred. Thus, there appears to be little advan-
tage in using the bootstrap for the analysis of SF-36 data,
particularly if one is interested in comparing mean
HRQoL between treatment groups.
5. Conclusions
In the datasets we studied, using the SF-36 as an outcome
measure, bootstrap methods produce results similar to
conventional statistical methods. This is likely because the
t-test and OLS multiple regression are robust to the viola-
tions of assumptions that HRQoL data are likely to cause
(i.e. non-Normality). While particular to our datasets,
these findings are likely to generalise to other HRQoL out-
comes, which have discrete, bounded and skewed distri-
butions. They may not generalise to HRQoL studies with
smaller sample sizes of less than 100 subjects. Future
research with other HRQoL outcome measures, interven-
tions and populations, is required to confirm this
conclusion.
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